The discovery of the MR receptor in adipose tissue, together with the finding that MR is overexpressed in adipose tissue of patients with obesity [22,23], has led to the hypothesis that MR can contribute to adipose tissue dysfunction and obesity-related complications by promoting inflammation, oxidative stress, and adipokine dysregulation. Here, NR3C2 is linked to obesity due to melanocortin 4 receptor deficiency.